Friday, March 3, 2017

(Smallish) Friday Federal Propecia®/Proscar® MDL Litigation Status Update


This item supplements the disclosure we mentioned earlier in the week, from Merck's SEC Form 10-K filing.

The parties entered a joint status report, as required this morning -- on the state of discovery, as to the five bellwethers set for trial beginning in March of 2018. Two more plaintiffs' science experts are to deliver documents, and likely be deposed, in the coming weeks.

That three page letter, as a PDF file, may be found here. But the upshot is that all remains on track.

Onward, on a blindingly-bright, clear azure blue -- and warming -- Friday, the first in this March. . . . (wondering here, if the power is back on, or if the deep freeze is still in full-effect). . . smile. . . .

नमस्ते

No comments: